AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 140 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,761 | +25.5% | 1,839 | -7.8% | 0.00% | – |
| Q2 2023 | $6,184 | +94.1% | 1,995 | -13.0% | 0.00% | – |
| Q1 2023 | $3,186 | -30.1% | 2,292 | 0.0% | 0.00% | – |
| Q4 2022 | $4,561 | +128.0% | 2,292 | +85.7% | 0.00% | – |
| Q3 2022 | $2,000 | -50.0% | 1,234 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 1,234 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -92.4% | 1,234 | -91.0% | 0.00% | – |
| Q4 2021 | $66,000 | -9.6% | 13,697 | 0.0% | 0.00% | – |
| Q3 2021 | $73,000 | +4.3% | 13,697 | 0.0% | 0.00% | – |
| Q2 2021 | $70,000 | -49.3% | 13,697 | -33.4% | 0.00% | – |
| Q1 2021 | $138,000 | +56.8% | 20,553 | +6.9% | 0.00% | – |
| Q4 2020 | $88,000 | +4.8% | 19,235 | -11.7% | 0.00% | – |
| Q3 2020 | $84,000 | -78.5% | 21,784 | -80.5% | 0.00% | -100.0% |
| Q1 2020 | $390,000 | – | 111,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |